Empery Digital Secures $25M Offering at Premium, Reduces Debt, and Navigates Proxy Contest
EMPD sits 37% above its 52-week low of $3.185.
Summary
Empery Digital finalized a $25 million registered direct offering at a premium to market price, using proceeds for debt reduction and strategically exempting the transaction from its poison pill amidst an activist proxy contest.
Key Events · Financing and Capital Events · EMPD
-
Secures $25 Million Registered Direct Offering
Empery Digital Inc. entered into a definitive agreement for a registered direct offering of 2,558,422 shares of common stock and pre-funded warrants to purchase 2,079,797 shares, along with accompanying common stock warrants to purchase 4,638,219 shares, raising approximately $25 million in gross proceeds.
-
Offering Priced at a Premium
The offering was priced at $5.39 per share (or pre-funded warrant), which is a significant premium to the current market price of $4.36, reflecting institutional confidence. The common warrants have an exercise price of $6.27.
-
Debt Reduction and Balance Sheet Optimization
Net proceeds, combined with cash on hand, will be used to reduce outstanding debt by approximately $40 million, including the full repayment of a $50 million Repo Facility and an incremental draw down of approximately $10 million on an existing credit facility.
-
Strategic Exemption from Rights Agreement
The Board of Directors declared the offering an 'Exempt Transaction' under the existing Rights Agreement (poison pill), preventing the triggering of anti-takeover provisions amidst an ongoing proxy contest with activist investor ATG Capital.
Analysis · EMPD · Manufacturing
This 8-K details a significant $25 million registered direct offering, which is crucial for Empery Digital Inc. given its ongoing activist investor situation. The offering is priced at $5.39 per share, a notable premium to the current market price of $4.36, reflecting institutional confidence. The proceeds will primarily be used to reduce outstanding debt by approximately $40 million, strengthening the company's balance sheet. Critically, the Board of Directors has exempted this transaction from the existing Rights Agreement (poison pill), allowing the capital raise to proceed without triggering anti-takeover provisions amidst a proxy contest launched by activist investor ATG Capital. This strategic maneuver provides capital while maintaining board control.
How filings like this one have moved
In the 30 days to Sep 12, 2026, 42% of the 479 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.44%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, EMPD was trading at $4.36 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $158.8M. The 52-week trading range was $3.19 to $68.48. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.